Intesticort

Budesonide, the active ingredient in Intesticort, is a corticosteroid presented as an oral formulation for systemic use. It is employed to reduce inflammation in the gastrointestinal tract of patients with Crohn's disease, ulcerative colitis, and eosinophilic esophagitis and related inflammatory conditions.

GNH USA supplies Intesticort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across multiple markets. Our distribution network ensures reliable delivery and support for therapeutic needs.

Budesonide is a glucocorticoid that modulates inflammatory pathways in the gastrointestinal tract.

Crohn's disease: reduces intestinal inflammation and helps maintain remission. Ulcerative colitis: decreases colonic inflammation and promotes symptom relief. Eosinophilic esophagitis: diminishes esophageal eosinophilic infiltration and improves swallowing function.

Budesonide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area. - Upper respiratory tract infection: symptoms such as sore throat or runny nose. - Dyspepsia: indigestion or upset stomach. - Mild insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Adrenal suppression: reduced endogenous cortisol production. - Severe infection: increased susceptibility to bacterial, viral, or fungal infections. - Osteoporosis: loss of bone density leading to fractures. - Hyperglycaemia: elevated blood glucose levels. - Visual disturbances: blurred vision or cataract formation. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications. - Assess adrenal function: check cortisol levels if long‑term use is planned. - Monitor for infection: watch for signs of bacterial or fungal infections. - Use lowest effective dose: titrate to the minimal dose that controls disease. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal. - Caution in hepatic impairment: dose adjustment may be required. - Store at ambient temperature: keep in the original pack, protect from moisture.

Budesonide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic exposure. - CYP3A4 inducers (e.g., rifampicin, phenytoin): may reduce therapeutic effect. - Live vaccines: risk of uncontrolled infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect. - Antidiabetic agents: possible hyperglycaemia requiring dose adjustment. - Other systemic steroids: additive immunosuppressive risk.